Bone metabolism and mineral density following renal transplantation.

نویسندگان

  • G S Reusz
  • A J Szabó
  • F Péter
  • E Kenesei
  • P Sallay
  • K Latta
  • A Szabó
  • T Tulassay
چکیده

AIM To study bone turnover following renal transplantation using a panel of biochemical markers and to correlate the results with both areal and volumetric bone mineral density (BMD). PATIENTS A total of 31 patients aged 18.1 years were transplanted 5.4 years before this study. Control patients (n = 31) were age and gender matched. METHODS In addition to measurement of biochemical markers, BMD was measured by single photon absorptiometry and peripheral quantitative computed tomography on the non-dominant radius. RESULTS Patients had reduced glomerular filtration rate, raised concentrations of serum phosphate, serum procollagene type I carboxy terminal propeptide, osteocalcin, and serum procollagene type I cross linked carboxy terminal telopeptide. The differences were still significant if only patients with normal intact parathyroid hormone were considered. BMD single photon absorptiometry Z score for age was significantly decreased. Following standardisation for height the differences were no longer present. With volumetric techniques patients had normal trabecular but decreased cortical and total BMD compared to age matched controls, but there was no difference from height matched controls. CONCLUSION Markers of bone turnover are increased following renal transplantation. However, the biochemical analysis did not allow conclusions to be drawn on the bone mineral content. BMD single photon absorptiometry Z score corrected for height and BMD measured by quantitative computed tomography compared to height matched controls were normal in paediatric renal transplantation patients. Height matched controls should be used in both areal and volumetric BMD measurements in states of growth failure.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی میزان افت تراکم استخوان پس از پیوند کلیه در 10 بیمار در بیمارستان هاشمی‌نژادAssessment of Reduction in Bone Density after Renal Transplantation in 10 Patients in Hasheminejad Hospital

    Background & Objective: Osteopenia is a common complication in renal transplant recipient resulting to increased rate of bone fracture especially in spine, ribs and hip. The purpose of this study was to examine the degree and pattern of bone loss in the first three months after renal transplantation. Method: This observational study was carried out on 10 renal transplant recipients(4 males,...

متن کامل

Is management of angiomyolipoma different after kidney transplantation?

mineral density changes within six months of renal transplantation. increased bone turnover and low bone density in long-term survivors to kidney transplantation. Posttransplant bone disease: evidence for a high bone resorption state. mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals. Comparison of alendronate and pamidronate on ...

متن کامل

Osteoporosis following solid organ transplantation

Damaris Vega & Khashayar Sakhaee† †Author for correspondence University of Texas Southwestern Medical Center, Department of Internal Medicine and, Charles & Jane Pak Center for Mineral Metabolism & Clinical Research, 5323 Harry Hines Boulevard, Dallas, TX 75390-8885, USA Tel.: +1 214 590 7783; Fax: +1 214 590 4091; khashayar.sakhaee@utsouth western.edu ‘Despite the introduction of new immunosup...

متن کامل

Factors affecting bone mineral density in renal transplant patients.

Bone disease is a major cause of morbidity in end stage renal failure. This study is aimed to assess the prevalence of abnormal bone mineral density (BMD), measured by dual photon absorptiometry (DPA) in the renal transplant population. Subjects consisted of 110 patients followed up after transplantation for between 1 and 17 years. Variables analyzed included age, sex, ethic origin, years and t...

متن کامل

Sclerostin blood levels before and after kidney transplantation.

BACKGROUND/AIMS Sclerostin is secreted by osteocytes. As a circulating inhibitor of the Wnt-signaling pathway it inhibits bone formation and contributes to the development of osteoporosis. Sclerostin levels are elevated in patients with chronic kidney disease and end-stage renal disease. Since data for patients after kidney transplantation are scarce, we have prospectively measured sclerostin l...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Archives of disease in childhood

دوره 83 2  شماره 

صفحات  -

تاریخ انتشار 2000